KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Change in Accured Expenses (2018 - 2025)

Vir Biotechnology's Change in Accured Expenses history spans 8 years, with the latest figure at $10.1 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 120.84% to $10.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.5 million, a 85.15% increase, with the full-year FY2025 number at -$9.5 million, up 85.15% from a year prior.
  • Change in Accured Expenses hit $10.1 million in Q4 2025 for Vir Biotechnology, up from -$14.2 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for VIR hit a ceiling of $433.6 million in Q1 2022 and a floor of -$288.2 million in Q2 2022.
  • Historically, Change in Accured Expenses has averaged -$19.5 million across 5 years, with a median of -$16.5 million in 2021.
  • The widest YoY moves for Change in Accured Expenses: up 2402.84% in 2022, down 8228.76% in 2022.
  • Tracing VIR's Change in Accured Expenses over 5 years: stood at $72.0 million in 2021, then tumbled by 212.04% to -$80.7 million in 2022, then surged by 48.02% to -$41.9 million in 2023, then decreased by 15.65% to -$48.5 million in 2024, then skyrocketed by 120.84% to $10.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for VIR at $10.1 million in Q4 2025, -$14.2 million in Q3 2025, and -$24.2 million in Q2 2025.